{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:20:57Z","timestamp":1791390057126,"version":"4.3.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10672-3","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T08:58:59Z","timestamp":1749805139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Insights for lncH19, miR-9, and miR-146a expression levels and their cross-talk with pro-inflammatory cytokines, copeptin, and neopterin profile in type 1 diabetic cardiomyopathy"],"prefix":"10.1007","volume":"52","author":[{"given":"Marwa A.","family":"Radwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil A.","family":"Hasona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel Abdel","family":"Moneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa M.","family":"Rabea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-034X","authenticated-orcid":false,"given":"Rehab G.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"10672_CR1","doi-asserted-by":"crossref","unstructured":"Gregory GA et al (2022) Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study, vol 10. The lancet Diabetes & endocrinology, pp 741\u2013760. 10","DOI":"10.1016\/S2213-8587(22)00218-2"},{"issue":"Suppl 1","key":"10672_CR2","first-page":"198","volume":"17","author":"J Tuomilehto","year":"2020","unstructured":"Tuomilehto J et al (2020) Update on worldwide trends in occurrence of childhood type 1 diabetes in 2020. Pediatr Endocrinol Reviews: PER 17(Suppl 1):198\u2013209","journal-title":"Pediatr Endocrinol Reviews: PER"},{"issue":"3","key":"10672_CR3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","volume":"10","author":"J Schofield","year":"2019","unstructured":"Schofield J, Ho J, Soran H (2019) Cardiovascular risk in type 1 diabetes mellitus. Diabetes Therapy 10(3):773\u2013789","journal-title":"Diabetes Therapy"},{"key":"10672_CR4","doi-asserted-by":"crossref","first-page":"695792","DOI":"10.3389\/fmed.2021.695792","volume":"8","author":"T Salvatore","year":"2021","unstructured":"Salvatore T et al (2021) The diabetic cardiomyopathy: the contributing pathophysiological mechanisms. Front Med (Lausanne) 8:695792","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10672_CR5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41420-023-01553-4","volume":"9","author":"JL Huo","year":"2023","unstructured":"Huo JL et al (2023) Diabetic cardiomyopathy: early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions. Cell Death Discov 9(1):256","journal-title":"Cell Death Discov"},{"key":"10672_CR6","unstructured":"Shu X et al (2024) Copeptin as a diagnostic and prognostic biomarker in pediatric diseases. Clinical Chemistry and Laboratory Medicine (CCLM) 2023(0)"},{"issue":"3","key":"10672_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/biom14030309","volume":"14","author":"R Licordari","year":"2024","unstructured":"Licordari R et al (2024) Beyond natriuretic peptides: unveiling the power of emerging biomarkers in heart failure. Biomolecules 14(3):309","journal-title":"Biomolecules"},{"key":"10672_CR8","doi-asserted-by":"crossref","unstructured":"Mahmoudvand G et al (2024) Neopterin as a potential biomarker for the early diagnosis of heart failure: A systematic review and Meta-analysis. Current Medicinal Chemistry","DOI":"10.2174\/0109298673258661231003045907"},{"issue":"7","key":"10672_CR9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/antiox7070080","volume":"7","author":"SP Gieseg","year":"2018","unstructured":"Gieseg SP, Baxter-Parker G, Lindsay A (2018) Neopterin, inflammation, and oxidative stress: what could we be missing? Antioxidants 7(7):80","journal-title":"Antioxidants"},{"issue":"11","key":"10672_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/jir.2020.0113","volume":"40","author":"M Rezaeepoor","year":"2020","unstructured":"Rezaeepoor M et al (2020) Evaluation of interleukin-23 and JAKs\/STATs\/SOCSs\/ROR-\u03b3t expression in type 2 diabetes mellitus patients treated with or without sitagliptin. J Interferon Cytokine Res 40(11):515\u2013523","journal-title":"J Interferon Cytokine Res"},{"issue":"4","key":"10672_CR11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/biomedicines12040765","volume":"12","author":"E Radzioch","year":"2024","unstructured":"Radzioch E et al (2024) Diabetic Cardiomyopathy\u2014From basics through diagnosis to treatment. Biomedicines 12(4):765","journal-title":"Biomedicines"},{"issue":"1","key":"10672_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s43044-024-00446-w","volume":"76","author":"A Taghdiri","year":"2024","unstructured":"Taghdiri A (2024) Cardiovascular biomarkers: exploring troponin and BNP applications in conditions related to carbon monoxide exposure. Egypt Heart J 76(1):9","journal-title":"Egypt Heart J"},{"key":"10672_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fmolb.2019.00091","volume":"6","author":"K Dhama","year":"2019","unstructured":"Dhama K et al (2019) Biomarkers in stress related diseases\/disorders: diagnostic, prognostic, and therapeutic values. Front Mol Biosci 6:91","journal-title":"Front Mol Biosci"},{"issue":"22","key":"10672_CR14","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.3390\/ijms222212165","volume":"22","author":"K Margaritis","year":"2021","unstructured":"Margaritis K et al (2021) Micro-RNA implications in type-1 diabetes mellitus: a review of literature. Int J Mol Sci 22(22):12165","journal-title":"Int J Mol Sci"},{"key":"10672_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-021-01245-2","volume":"20","author":"D Jakubik","year":"2021","unstructured":"Jakubik D et al (2021) MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics. Cardiovasc Diabetol 20:1\u201329","journal-title":"Cardiovasc Diabetol"},{"key":"10672_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-021-03142-4","volume":"19","author":"F Barutta","year":"2021","unstructured":"Barutta F et al (2021) MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS. J Translational Med 19:1\u201310","journal-title":"J Translational Med"},{"issue":"7","key":"10672_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.64.7.13","volume":"64","author":"E Wang","year":"2023","unstructured":"Wang E, Feng B, Chakrabarti S (2023) MicroRNA 9 is a regulator of endothelial to mesenchymal transition in diabetic retinopathy. Investig Ophthalmol Vis Sci 64(7):13\u201313","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10672_CR18","doi-asserted-by":"crossref","unstructured":"Dandare A et al (2023) Clinical relevance of Circulating non-coding RNAs in metabolic diseases: emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome, vol 10. Genes & Diseases, pp 2393\u20132413. 6","DOI":"10.1016\/j.gendis.2022.05.022"},{"key":"10672_CR19","unstructured":"Organization WH (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, diagnosis and classification of diabetes mellitus. World health organization"},{"issue":"6","key":"10672_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499\u2013502","journal-title":"Clin Chem"},{"key":"10672_CR21","unstructured":"Hamza DA, Ali AM, Hameed AH (2019) THE ESTIMATION OF GPT AND GOT ENZYMES FOR DIABETES PATIENTS: A BIOCHEMICAL STUDY, vol 19. Biochemical & Cellular Archives, 2"},{"issue":"1","key":"10672_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.15171\/apb.2016.015","volume":"6","author":"F Habibi","year":"2016","unstructured":"Habibi F et al (2016) Alteration in inflammation-related miR-146a expression in NF-KB signaling pathway in diabetic rat hippocampus. Adv Pharm Bull 6(1):99","journal-title":"Adv Pharm Bull"},{"issue":"4","key":"10672_CR23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013 \u2206\u2206CT method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"issue":"2","key":"10672_CR24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2337\/dc14-0920","volume":"38","author":"K Khunti","year":"2015","unstructured":"Khunti K et al (2015) Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care 38(2):316\u2013322","journal-title":"Diabetes Care"},{"issue":"4","key":"10672_CR25","doi-asserted-by":"crossref","first-page":"107833","DOI":"10.1016\/j.jdiacomp.2020.107833","volume":"35","author":"X Cai","year":"2021","unstructured":"Cai X et al (2021) Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease. J Diabetes Complicat 35(4):107833","journal-title":"J Diabetes Complicat"},{"key":"10672_CR26","doi-asserted-by":"crossref","unstructured":"Hasona NA et al (2023) Osteocalcin, miR-143, and miR-145 expression in long-standing type 1 diabetes mellitus and their correlation with HbA1c. Indian J Clin Biochem 1\u20138","DOI":"10.1007\/s12291-023-01131-6"},{"key":"10672_CR27","doi-asserted-by":"crossref","first-page":"102294","DOI":"10.1016\/j.jaut.2019.06.005","volume":"105","author":"I Zentsova","year":"2019","unstructured":"Zentsova I et al (2019) Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients. J Autoimmun 105:102294","journal-title":"J Autoimmun"},{"issue":"7","key":"10672_CR28","first-page":"4838","volume":"14","author":"J Alkaabi","year":"2022","unstructured":"Alkaabi J et al (2022) Relationship between lipid profile, inflammatory and endothelial dysfunction biomarkers, and type 1 diabetes mellitus: A case-control study. Am J Translational Res 14(7):4838","journal-title":"Am J Translational Res"},{"key":"10672_CR29","doi-asserted-by":"crossref","unstructured":"Abdel-Moneim A, Bakery HH, Allam G (2018) The potential pathogenic role of IL-17\/Th17 cells in both type 1 and type 2 diabetes mellitus. Biomedicine & Pharmacotherapy 101:287\u2013292","DOI":"10.1016\/j.biopha.2018.02.103"},{"issue":"1","key":"10672_CR30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12933-021-01437-w","volume":"21","author":"A Wegeberg","year":"2022","unstructured":"Wegeberg A et al (2022) Elevated levels of interleukin-12\/23p40 May serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes. Cardiovasc Diabetol 21(1):5","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10672_CR31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s13238-018-0505-z","volume":"9","author":"Y Hou","year":"2018","unstructured":"Hou Y et al (2018) IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis. Protein Cell 9(12):1027\u20131038","journal-title":"Protein Cell"},{"key":"10672_CR32","doi-asserted-by":"crossref","first-page":"909760","DOI":"10.3389\/fimmu.2022.909760","volume":"13","author":"DM Schwartz","year":"2022","unstructured":"Schwartz DM et al (2022) PET\/CT-based characterization of 18F-FDG uptake in various tissues reveals novel potential contributions to coronary artery disease in psoriatic arthritis. Front Immunol 13:909760","journal-title":"Front Immunol"},{"key":"10672_CR33","doi-asserted-by":"crossref","first-page":"115958","DOI":"10.1016\/j.biopha.2023.115958","volume":"170","author":"J Luo","year":"2024","unstructured":"Luo J et al (2024) Targeting IL-12 family cytokines: A potential strategy for type 1 and type 2 diabetes mellitus. Biomed Pharmacother 170:115958","journal-title":"Biomed Pharmacother"},{"key":"10672_CR34","doi-asserted-by":"crossref","unstructured":"Koosha P et al (2020) High sensitivity C-reactive protein predictive value for cardiovascular disease: a nested case control from Isfahan cohort study (ICS). Global Heart 15(1)","DOI":"10.5334\/gh.367"},{"issue":"6","key":"10672_CR35","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1373\/clinchem.2008.118844","volume":"55","author":"TB Grammer","year":"2009","unstructured":"Grammer TB et al (2009) Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen risk and cardiovascular health study. Clin Chem 55(6):1135\u20131146","journal-title":"Clin Chem"},{"key":"10672_CR36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.intimp.2018.03.026","volume":"59","author":"NS Elbarbary","year":"2018","unstructured":"Elbarbary NS et al (2018) Role of neopterin as a biochemical marker for peripheral neuropathy in pediatric patients with type 1 diabetes: relation to nerve conduction studies. Int Immunopharmacol 59:68\u201375","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10672_CR37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/15701611113119990003","volume":"13","author":"M Neri","year":"2015","unstructured":"Neri M et al (2015) Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr Vasc Pharmacol 13(1):26\u201336","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"10672_CR38","doi-asserted-by":"crossref","first-page":"9124676","DOI":"10.1155\/2016\/9124676","volume":"2016","author":"MA G\u00f3mez-Marcos","year":"2016","unstructured":"G\u00f3mez-Marcos MA et al (2016) Serum superoxide dismutase is associated with vascular structure and function in hypertensive and diabetic patients. Oxidative Med Cell Longev 2016(1):9124676","journal-title":"Oxidative Med Cell Longev"},{"issue":"3","key":"10672_CR39","first-page":"95","volume":"3","author":"M Fathelbab","year":"2017","unstructured":"Fathelbab M et al (2017) A putative role for oxidative stress in pathophysiology of diabetic cardiomyopathy. Egypt J Obes Diabetes Endocrinol 3(3):95\u201399","journal-title":"Egypt J Obes Diabetes Endocrinol"},{"issue":"14","key":"10672_CR40","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363(14):1341\u20131350","journal-title":"N Engl J Med"},{"issue":"5","key":"10672_CR41","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/ijms21051835","volume":"21","author":"A Poznyak","year":"2020","unstructured":"Poznyak A et al (2020) The diabetes mellitus\u2013atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci 21(5):1835","journal-title":"Int J Mol Sci"},{"key":"10672_CR42","unstructured":"Mohamed NH, Akasha R (2019) Evaluation of Serum Creatine kinase Activity in Sudanese Patients with Type1 and Type2 Diabetes Mellitus in Khartoum State."},{"issue":"1","key":"10672_CR43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ndt\/gfaa308","volume":"37","author":"NS Heinrich","year":"2022","unstructured":"Heinrich NS et al (2022) Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes. Nephrol Dialysis Transplantation 37(1):100\u2013107","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"6","key":"10672_CR44","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jdiacomp.2016.04.012","volume":"30","author":"P Bjornstad","year":"2016","unstructured":"Bjornstad P et al (2016) Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes. J Diabetes Complicat 30(6):1093\u20131096","journal-title":"J Diabetes Complicat"},{"key":"10672_CR45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.diabres.2016.06.019","volume":"118","author":"R Schiel","year":"2016","unstructured":"Schiel R et al (2016) Plasma copeptin in children and adolescents with type 1 diabetes mellitus in comparison to healthy controls. Diabetes Res Clin Pract 118:156\u2013161","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10672_CR46","first-page":"7196280","volume":"2016","author":"L Faloppi","year":"2016","unstructured":"Faloppi L et al (2016) Lactate dehydrogenase in hepatocellular carcinoma: something old, something new. Biomed Res Int 2016(1):7196280","journal-title":"Biomed Res Int"},{"issue":"10","key":"10672_CR47","doi-asserted-by":"crossref","first-page":"e0276076","DOI":"10.1371\/journal.pone.0276076","volume":"17","author":"B Feng","year":"2022","unstructured":"Feng B et al (2022) Endothelial derived miRNA-9 mediated cardiac fibrosis in diabetes and its regulation by ZFAS1. PLoS ONE 17(10):e0276076","journal-title":"PLoS ONE"},{"issue":"1","key":"10672_CR48","first-page":"8406438","volume":"2019","author":"Y Liu","year":"2019","unstructured":"Liu Y et al (2019) Decreased serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181a in autoimmune diabetes: potential biomarkers for diagnosis and possible involvement in pathogenesis. Int J Endocrinol 2019(1):8406438","journal-title":"Int J Endocrinol"},{"issue":"3","key":"10672_CR49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbrc.2017.06.196","volume":"498","author":"G Wang","year":"2018","unstructured":"Wang G et al (2018) Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: association with ongoing islet autoimmunity. Biochem Biophys Res Commun 498(3):382\u2013387","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10672_CR50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cellimm.2009.10.012","volume":"260","author":"R Hezova","year":"2010","unstructured":"Hezova R et al (2010) microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol 260(2):70\u201374","journal-title":"Cell Immunol"},{"issue":"7","key":"10672_CR51","doi-asserted-by":"crossref","first-page":"e0302772","DOI":"10.1371\/journal.pone.0302772","volume":"19","author":"H Wang","year":"2024","unstructured":"Wang H et al (2024) CircRNA_012164\/MicroRNA-9-5p axis mediates cardiac fibrosis in diabetic cardiomyopathy. PLoS ONE 19(7):e0302772","journal-title":"PLoS ONE"},{"issue":"5","key":"10672_CR52","doi-asserted-by":"crossref","first-page":"e0126957","DOI":"10.1371\/journal.pone.0126957","volume":"10","author":"TM Motawae","year":"2015","unstructured":"Motawae TM et al (2015) MicroRNAs 9 and 370 association with biochemical markers in T2D and CAD complication of T2D. PLoS ONE 10(5):e0126957","journal-title":"PLoS ONE"},{"issue":"1","key":"10672_CR53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2011.93","volume":"90","author":"C Herder","year":"2011","unstructured":"Herder C, Karakas M, Koenig W (2011) Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 90(1):52\u201366","journal-title":"Clin Pharmacol Ther"},{"key":"10672_CR54","doi-asserted-by":"crossref","unstructured":"Lovis P, Gattesco S, Regazzi R (2008) Regul Expression Compon Exocytotic Mach insulin-secreting Cells microRNAs","DOI":"10.1515\/BC.2008.026"},{"key":"10672_CR55","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s10529-017-2390-6","volume":"39","author":"Y Xiao","year":"2017","unstructured":"Xiao Y et al (2017) Diabetic nephropathy: serum miR-9 confers a poor prognosis in and is associated with level changes of vascular endothelial growth factor and pigment epithelium-derived factor. Biotechnol Lett 39:1583\u20131590","journal-title":"Biotechnol Lett"},{"issue":"1","key":"10672_CR56","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1038\/s41598-017-07611-z","volume":"7","author":"Z Zhang","year":"2017","unstructured":"Zhang Z et al (2017) Increased plasma levels of LncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population. Sci Rep 7(1):7491","journal-title":"Sci Rep"},{"issue":"2","key":"10672_CR57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/1806-9282.65.2.110","volume":"65","author":"Y Yao","year":"2019","unstructured":"Yao Y et al (2019) The overexpression of LncRNA H19 as a diagnostic marker for coronary artery disease. Revista Da Associa\u00e7\u00e3o M\u00e9dica Brasileira 65(2):110\u2013117","journal-title":"Revista Da Associa\u00e7\u00e3o M\u00e9dica Brasileira"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10672-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10672-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10672-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:26:53Z","timestamp":1766852813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10672-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10672"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10672-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki, and the informed consent was approved by the Ethics Committee at the Faculty of Medicine, Beni-Suef University provided its approval (FMBSUREC\/03102023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"592"}}